KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Long-Term Investments: 2014-2024

Historic Long-Term Investments for Quest Diagnostics (DGX) over the last 11 years, with Dec 2024 value amounting to $123.0 million.

  • Quest Diagnostics' Long-Term Investments rose 9.60% to $137.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $137.0 million, marking a year-over-year increase of 9.60%. This contributed to the annual value of $123.0 million for FY2024, which is 8.89% down from last year.
  • Per Quest Diagnostics' latest filing, its Long-Term Investments stood at $123.0 million for FY2024, which was down 8.89% from $135.0 million recorded in FY2023.
  • Over the past 5 years, Quest Diagnostics' Long-Term Investments peaked at $521.0 million during FY2020, and registered a low of $123.0 million during FY2024.
  • Moreover, its 3-year median value for Long-Term Investments was $132.0 million (2022), whereas its average is $130.0 million.
  • Its Long-Term Investments has fluctuated over the past 5 years, first increased by 8.09% in 2020, then tumbled by 72.94% in 2021.
  • Yearly analysis of 5 years shows Quest Diagnostics' Long-Term Investments stood at $521.0 million in 2020, then crashed by 72.94% to $141.0 million in 2021, then fell by 6.38% to $132.0 million in 2022, then climbed by 2.27% to $135.0 million in 2023, then dropped by 8.89% to $123.0 million in 2024.